		Technical Data
K0005-16E	Kallikrein 13, CT (KLK13, Kallikrein-related Peptidase 13, Kallikrein-like Protein 4, KLKL4, KLK-L4, DKFZp586J1923)

Description:
Kallikreins are a subgroup of serine proteases having diverse physiological functions. Growing evidence suggests that many kallikreins are implicated in carcinogenesis and some have potential as novel cancer and other disease biomarkers. Expression of KLK13 is regulated by steroid hormones and may be useful as a marker for breast cancer.

Applications:
Suitable for use in ELISA and Western Blot. Other applications not tested.

Recommended Dilution:
ELISA: 1:1,000
Western Blot: 1:50-1:100
Optimal dilutions to be determined by the researcher.

Storage and Stability:
May be stored at 4°C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20°C. Aliquots are stable for at least 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

Type	Isotype	Clone	Grade
Pab	IgG		Purified

Size		Storage	Shipping	Source	Host
100ug		-20°C	Blue Ice	Human	Rabbit

Concentration:

~0.25mg/ml

Immunogen:

Synthetic peptide selected from the C-terminal region of human KLK13 (KLH).

Purity:

Purified by ammonium sulfate precipitation.

Form

Supplied as a liquid in PBS, 0.09% sodium azide.

Specificity:

Recognizes human KLK13.

Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.

1.Kapadia, C., et al., Biochem. Biophys. Res. Commun. 323(3):1084-1090 (2004). 2.Petraki, C.D., et al., Prostate Cancer Prostatic Dis. 6(3):223-227 (2003). 3.Chang, A., et al., Br. J. Cancer 86(9):1457-1464 (2002). 4.Chang, A., et al., Anticancer Res. 21(5):3147-3152 (2001). 5.Diamandis, E.P., et al., Trends Endocrinol. Metab. 11(2):54-60 (2000).